# H 16868

## Common misspellings for H 16868:

g 16868, b 16868, n 16868, j 16868, u 16868, y 16868, h 26868, h q6868, h 15868, h 1t868, h 1y868, h 17868, h 16768, h 16u68, h 16i68, h 16968, h 16858, h 168t8, h 168y8, h 16878, h 16867, h 1686u, h 1686i, h 16869, gh 16868, hg 16868, bh 16868, hb 16868, nh 16868, hn 16868, jh 16868, hj 16868, uh 16868, hu 16868, yh 16868, hy 16868, h 216868, h 126868, h q16868, h 1q6868, h 156868, h 165868, h 1t6868, h 16t868, h 1y6868, h 16y868, h 176868, h 167868, h 168768, h 16u868, h 168u68, h 16i868, h 168i68, h 169868, h 168968, h 168568, h 168658, h 168t68, h 1686t8, h 168y68, h 1686y8, h 168678, h 168687, h 1686u8, h 16868u, h 1686i8, h 16868i, h 168698, h 168689, 16868, h16868, h 6868, h 1868, h 1668, h 1688, h 1686, h1 6868, h 61868, h 18668, h 16688, h 16886, hh 16868, h 16868, h 116868, h 166868, h 168868, h 168668, h 168688, x 16868, l 16868, i 16868, H016868, H 96868, H 56868, H 36868, H 06868, H 1v868, H 12868, H 14868, H 16x68, H 16068, H 168v8, H 16828, H 16848, H 1686x, H 16860, h 1 6868, h 16 868, h 168 68, h 1686 8.

## Definition of H 16868:

- A highly effective inhibitor of gastric acid secretion used in the therapy of gastric ulcers and Zollinger- Ellison syndrome. The drug inhibits the H(+)- K(+)- ATPase ( H(+)- K(+)- EXCHANGING ATPASE) in a pH- dependent manner. This ATPase is considered the proton pump in the secretory membrane of the parietal cell.